A new approach to treating inflammatory diseases through personalised probiotic therapies -- also known as precision medicine -- has been proposed by researchers.
A new approach to treating inflammatory diseases through personalised probiotic therapies – also known as precision medicine – has been proposed by researchers at the University of Surrey.
Metabolic diseases occur when the body's usual metabolic processes are disrupted. These diseases can be congenital or acquired, for example, diabetes and phenylketonuria.
An atlas of the associations between the use of GLP-1 receptor agonists (GLP-1RAs) and 175 health outcomes reports the effectiveness and risks of GLP-1RAs compared with other antihyperglycemic ...
Participants with metabolic syndrome who received 1,700 mg metformin daily with or without a Mediterranean diet intervention had reduced incidence of diabetes compared with placebo, according to ...